Core IM | Internal Medicine Podcast cover image

#99 Bleeding vs. Clotting Risk: Gray Matters Segment

Core IM | Internal Medicine Podcast

00:00

Cancer Die

The longer I treat this patient's PE the less likely it is to recur with stopping anticoagulation. The number of sides of my dad goes up and it becomes maybe a one in 20 chance or a one in 50 chance that the PE progresses. We're rolling another dice by delaying the biopsy which can go from curable to incurable. And not only that but I actually don't even know which cancer die I'm rolling which would change the number of sides and how quickly they change. So what happened next? He started him on a pixivan and we planned to have him on the a p Pixivan for one month and then hold it for three days prior to

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app